BDF Gestion Sells 3,545 Shares of Encompass Health Co. (NYSE:EHC)

BDF Gestion reduced its position in shares of Encompass Health Co. (NYSE:EHC) by 11.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 27,292 shares of the company’s stock after selling 3,545 shares during the quarter. BDF Gestion’s holdings in Encompass Health were worth $2,520,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of EHC. Point72 Asset Management L.P. increased its stake in Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after purchasing an additional 835,135 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in Encompass Health by 26.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after purchasing an additional 156,938 shares in the last quarter. Franklin Resources Inc. increased its stake in Encompass Health by 22.0% during the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock valued at $67,412,000 after purchasing an additional 126,000 shares in the last quarter. Algert Global LLC increased its stake in Encompass Health by 89.5% during the 3rd quarter. Algert Global LLC now owns 150,570 shares of the company’s stock valued at $14,551,000 after purchasing an additional 71,132 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new stake in Encompass Health during the 3rd quarter valued at about $4,241,000. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Performance

Shares of EHC opened at $95.93 on Thursday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business has a 50-day simple moving average of $96.58 and a two-hundred day simple moving average of $94.58. The stock has a market cap of $9.66 billion, a price-to-earnings ratio of 23.17, a PEG ratio of 1.13 and a beta of 0.89. Encompass Health Co. has a 52 week low of $70.83 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.86 earnings per share. On average, analysts expect that Encompass Health Co. will post 4.29 EPS for the current year.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of analyst reports. KeyCorp raised their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Royal Bank of Canada lifted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Finally, Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.